We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
-3.5%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
–
AUM
$217M
AUM Growth
-$7.82M
Cap. Flow
+$2.35M
Cap. Flow %
1.08%
Top 10 Hldgs %
37.08%
Holding
944
New
14
Increased
196
Reduced
207
Closed
16

Top Buys

Rank Stock Value
1
DOV icon
Dover
DOV
+$3.14M
2
ENPH icon
Enphase Energy
ENPH
+$1.55M
3
GTLS
Chart Industries
GTLS
+$1.36M
4
ON icon
ON Semiconductor
ON
+$1.32M
5
NEE icon
NextEra Energy
NEE
+$1.02M

Top Sells

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$1.71M
2
AY
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
+$821K
3
CRSP icon
CRISPR Therapeutics
CRSP
+$818K
4
PNC icon
PNC Financial Services
PNC
+$788K
5
AGO icon
Assured Guaranty
AGO
+$698K

Sector Composition

Rank Sector Weight
1 Technology 41.16%
2 Healthcare 11.03%
3 Consumer Staples 7.01%
4 Financials 6.41%
5 Industrials 6.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STHO icon
826
Star Holdings Shares of Beneficial Interest
STHO
$112M
$150 ﹤0.01%
12
– –
RBLX icon
827
Roblox
RBLX
$34B
$145 ﹤0.01%
5
– –
TVRD
828
Tvardi Therapeutics
TVRD
$23.5M
$134 ﹤0.01%
2
– –
SPHD icon
829
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.36B
$118 ﹤0.01%
3
– –
AGEN
830
Agenus
AGEN
$249M
$113 ﹤0.01%
5
– –
VEU icon
831
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$104 ﹤0.01%
2
– –
VTEB icon
832
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.1B
$96 ﹤0.01%
2
– –
EHAB
833
DELISTED
Enhabit
EHAB
$79 ﹤0.01%
7
– –
GTX icon
834
Garrett Motion
GTX
$5.9B
$79 ﹤0.01%
10
– –
CNDT icon
835
Conduent
CNDT
$230M
$70 ﹤0.01%
20
– –
GAIA icon
836
Gaia
GAIA
$47.3M
$54 ﹤0.01%
20
– –
CHRN
837
ChronoScale Holdings
CHRN
$3.12B
$23 ﹤0.01%
2
– –
RAD
838
DELISTED
Rite Aid Corporation
RAD
$22 ﹤0.01%
50
– –
RLMD icon
839
Relmada Therapeutics
RLMD
$544M
$18 ﹤0.01%
6
– –
GTBP icon
840
GT Biopharma
GTBP
$11.7M
$14 ﹤0.01%
2
– –
CRDF icon
841
Cardiff Oncology
CRDF
$64.3M
$3 ﹤0.01%
2
– –
MBOT icon
842
Microbot Medical
MBOT
$115M
$1 ﹤0.01%
1
– –
DOCU
843
DocuSign
DOCU
$9.63B
– –
-115
Closed -$6K
F icon
844
Ford
F
$57.3B
– –
-1,500
Closed -$23K
FBIN icon
845
Fortune Brands Innovations
FBIN
$6.12B
– –
-1,148
Closed -$83K
FBT icon
846
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.8B
– –
-15
Closed -$2K
FCVT icon
847
First Trust SSI Strategic Convertible Securities ETF
FCVT
$111M
– –
-500
Closed -$16K
FXH icon
848
First Trust Health Care AlphaDEX Fund
FXH
$1.02B
– –
-20
Closed -$2K
GIL icon
849
Gildan
GIL
$9.25B
– –
-616
Closed -$20K
ICLN icon
850
iShares Global Clean Energy ETF
ICLN
$2.38B
– –
-250
Closed -$5K
31 32 33
34
35

Similar funds

SM
Skaana Management Brooklyn, New York $296M AUM 65.1% 1-Year Est. Return
RHP
Royal Harbor Partners Houston, Texas $295M AUM 14.06% 1-Year Est. Return
MSWM
Master's Wealth Management Lancaster, Pennsylvania $295M AUM 15.96% 1-Year Est. Return
RLIM
Red Lighthouse Investment Management New York $296M AUM 22.04% 1-Year Est. Return
JCM
Jacobsen Capital Management Salt Lake City, Utah $296M AUM 24.47% 1-Year Est. Return
CA
Claar Advisors New York $295M AUM 12.26% 1-Year Est. Return
NRC
New Republic Capital Charlotte, North Carolina $297M AUM 24.5% 1-Year Est. Return
MFC
Morris Financial Concepts Mount Pleasant, South Carolina $295M AUM 17.25% 1-Year Est. Return

Front Row Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Front Row Advisors held 944 positions worth $217M, down 3.5% from $225M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 3.2%. Front Row Advisors opened 14 new positions and exited 16, leaving the 944-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 41% of assets, down from 42% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Front Row Advisors's largest Q3 2023 buy was Enphase Energy: 10,850 shares worth $1.3M.
  • Front Row Advisors added most to Dover in Q3 2023, an estimated $3.14M increase.
  • Front Row Advisors's biggest Q3 2023 reduction was Idexx Laboratories, cutting an estimated $1.71M.
  • Front Row Advisors fully exited Fortune Brands Innovations in Q3 2023, selling an estimated $83K.
  • Front Row Advisors's ten largest holdings make up 37% of its $217M portfolio in Q3 2023.
  • Front Row Advisors opened 14 new positions and closed 16 in Q3 2023.
  • Front Row Advisors's portfolio value fell 3.5% quarter-over-quarter to $217M.

Based on Front Row Advisors's 13F filing for Q3 2023, filed 15 Nov 2023.